Topotecan Completed Phase 1 / 2 Trials for Myelodysplastic Syndromes / Leukemias Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT00002588Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia
NCT00002705Topotecan in Treating Children With Refractory Leukemia
NCT00005593Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome
NCT00462787Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Leukemia